In conclusion, higher CT-1 levels in diabetic patients may promote cardiomyocyte hypertrophy and increased myocardial collagen content, and detecting changes in plasma CT-1 levels in diabetic patients may aid in the early diagnosis and prognosis of DCM. Here, CTF1 is linked to familial dilated cardiomyopathy.